Pharmacokinetic analyses
All 17 patients were evaluable for first dose noncompartmental pharmacokinetic analysis. First dose NEO-201 serum concentration–time profiles were measured for all 17 patients across the three different dose levels (Fig. Clinical Pharmacokinetics of NEO-201 Relevant PK parameters during dense PK sampling were calculated following the first dose given on C1D1 (Fig. 